Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The WIN symposium 2019
Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
25 Apr 2019
An overview of the WIN consortium
Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncolo...
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019
Making oncology global with the WIN consortium
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019
The translational element of the WIN consortium
Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019
How the WIN consortium achieves its goals
Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019
BGICC 2019
BGICC 2019 (  )
28 Jan 2019
Blinatumomab as second salvage therapy in adults with relapsed/refractory aggres...
Prof Alessandro Rambaldi - University of Milan, Milan, Italy
Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-NHL ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )
13 Dec 2018
Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for ...
Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for children with acute leukaemia ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )
6 Dec 2018
Daratumumab increases PFS in patients with transplant-ineligible multiple myelom...
Prof Thierry Facon - Hôpital Claude Huriez, Lille, France
Daratumumab increases PFS in patients with transplant-ineligible multiple myeloma ( Prof Thierry Facon - Hôpital Claude Huriez, Lille, France )
6 Dec 2018
Daratumumab found to increase PFS in patients with transplant-ineligible newly d...
Prof Thierry Facon - Hôpital Claude Huriez, Lille, France
Daratumumab found to increase PFS in patients with transplant-ineligible newly diagnosed multiple myeloma ( Prof Thierry Facon - Hôpital Claude Huriez, Lille, France )
4 Dec 2018
Myeloma XI study: Quadruplet regimen for transplant eligible patients
Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK
Myeloma XI study: Quadruplet regimen for transplant eligible patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )
3 Dec 2018
The benefits of a stem cell transplant after CAR T-cell therapy in paediatric pa...
Dr Corinne Summers - Seattle Children's Hospital, Seattle, USA
The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients ( Dr Corinne Summers - Seattle Children's Hospital, Seattle, USA )
2 Dec 2018